Acute respiratory distress syndrome (ARDS) is a heterogeneous clinical syndrome.
Understanding of the complex pathways involved in lung injury pathogenesis, resolution …

Although the acute respiratory distress syndrome (ARDS) is well defined by the
development of acute hypoxemia, bilateral infiltrates and non-cardiogenic pulmonary …

The diagnosis of acute respiratory distress syndrome (ARDS) traditionally requires
calculation of the ratio of partial pressure of arterial oxygen to fraction of inspired oxygen …

Acute lung injury is characterized by acute respiratory insufficiency with tachypnea, cyanosis
refractory to oxygen, decreased lung compliance, and diffuse alveolar infiltrates on chest X …

The acute respiratory distress syndrome (ARDS) is a common cause of respiratory failure in
critically ill patients and is defined by the acute onset of noncardiogenic pulmonary oedema …

Acute lung injury (ALI) affects over 10% of patients hospitalised in critical care, with acute
respiratory distress syndrome (ARDS) being the most severe form of ALI and having a …

This year is the 50th anniversary of the first description of acute respiratory distress
syndrome (ARDS). Since then, much has been learned about the pathogenesis of lung …

Sepsis-induced acute respiratory distress syndrome (ARDS) has high morbidity and
mortality and arises after lung infection or infection at extrapulmonary sites. An aberrant host …

Identifying new effective treatments for the acute respiratory distress syndrome (ARDS),
including COVID-19 ARDS, remains a challenge. The field of ARDS investigation is moving …

Active discussions are ongoing concerning the efficacy of systemic corticosteroids in COVID-
19, with evidence to support1 and advising against2 their use. Illustratively, a Review3 of …